SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000886163-13-000047
Filing Date
2013-06-04
Accepted
2013-06-04 17:03:04
Documents
2
Effectiveness Date
2013-06-04

Document Format Files

Seq Description Document Type Size
1 DEFA14A ligand2013proxysupplement.htm DEFA14A 239702
2 ligandlogo.jpg GRAPHIC 36525
  Complete submission text file 0000886163-13-000047.txt   291186
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33093 | Film No.: 13892037
SIC: 2834 Pharmaceutical Preparations